<--- Back to Details
First PageDocument Content
Connective tissue diseases / Medicine / Mucinoses / Rheumatology / Systemic scleroderma / Scleroderma / Morphea / CREST syndrome / Linear scleroderma / Anatomy / Autoimmune diseases / Health
Date: 2011-05-19 09:19:34
Connective tissue diseases
Medicine
Mucinoses
Rheumatology
Systemic scleroderma
Scleroderma
Morphea
CREST syndrome
Linear scleroderma
Anatomy
Autoimmune diseases
Health

Understanding & Managing Scleroderma UK Registered Charity Number[removed]Number[removed]

Add to Reading List

Source URL: www.sclerodermasociety.co.uk

Download Document from Source Website

File Size: 2,08 MB

Share Document on Facebook

Similar Documents

PRESS RELEASE  Genkyotex’s GKT137831 Granted Orphan Drug Designation in the US and EU for the Treatment of Systemic Sclerosis Geneva, Switzerland, and Archamps, France, 11th November, 2015 – Genkyotex, the leading de

PRESS RELEASE Genkyotex’s GKT137831 Granted Orphan Drug Designation in the US and EU for the Treatment of Systemic Sclerosis Geneva, Switzerland, and Archamps, France, 11th November, 2015 – Genkyotex, the leading de

DocID: 1qCta - View Document

Technology Opportunity, Ref. No. UZNovel Pharmacological Treatment of Scleroderma This invention relates to a novel pharmacological treatment of scleroderma comprising the administration of miR-29.

Technology Opportunity, Ref. No. UZNovel Pharmacological Treatment of Scleroderma This invention relates to a novel pharmacological treatment of scleroderma comprising the administration of miR-29.

DocID: 1pOlw - View Document

Privacy Policy* April, 2015 The Scleroderma Society of Canada is committed to protecting the privacy of the personal information of its employees, volunteers, members, customers, donors and other stakeholders. We value t

Privacy Policy* April, 2015 The Scleroderma Society of Canada is committed to protecting the privacy of the personal information of its employees, volunteers, members, customers, donors and other stakeholders. We value t

DocID: 1af4J - View Document

Soluble CD90 as biomarker of pulmonary complications in Systemic Sclerosis A new serological two-staged biomarker of pulmonaryarterial hypertension and pulmonary fibrosis Subtitle  Technology

Soluble CD90 as biomarker of pulmonary complications in Systemic Sclerosis A new serological two-staged biomarker of pulmonaryarterial hypertension and pulmonary fibrosis Subtitle Technology

DocID: 19Tlu - View Document

Microsoft Word - Ad for Recruitment for Survey26_FINAL.docx

Microsoft Word - Ad for Recruitment for Survey26_FINAL.docx

DocID: 19Pe8 - View Document